Real-World Evidence for the Safety and Efficacy of CGRP Monoclonal Antibody Therapy Added to OnabotulinumtoxinA Treatment for Migraine Prevention in Adult Patients With Chronic Migraine

被引：0

作者：

Mechtler, Laszlo ^{[1
]}

Saikali, Nicolas ^{[1
]}

McVige, Jennifer ^{[1
]}

Hughes, Olivia ^{[2
]}

Traut, Alexandra ^{[3
]}

Adams, Aubrey ^{[3
]}

机构：

[1] DENT Neurol Inst, Amherst, NY 14226 USA

[2] ICON Plc, Boston, MA USA

[3] AbbVie, Irvine, CA USA

来源：

关键词：

Calcitonin gene-related peptide; Concomitant treatment; Migraine prevention; OnabotulinumtoxinA; Real-world; Safety;

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：S39 / S40

页数：2